May 2016 Issue of The Ophthalmologist

Those on our Power List typically credit their achievements to “being in the right place at the right time” – but what about those (also doing heroic work) who weren’t?

iPSCs are routinely derived from fibroblasts and blood cells, but does the age of the donor matter?

In the quest to unearth alternative treatment strategies that don't rely on VEGF inhibition, researchers made some surprising discoveries...

From keratoconic to embryonic: the eye drop that promises to reinforce the cornea by inducing keratocytes to produce embryonic collagen

Novel compounds prevent disease progression in mouse models of glaucoma

Might increasing periods of bed rest affect CCT?

Boosting banana carotenoid levels could reduce vision loss – particularly in Africa and Southeast Asia

The five-year follow-up data are in. Half of all patients retain BCVA of 20/40 or better, irrespective of drug used

CXL gets the green light in the USA, Valeant announces new CEO, and Alcon teams up with PowerVision

Aqueous angiography promises a revelation in aqueous humor outflow understanding – and could transform MIGS outcomes

How can you predict which patients will develop keratectasia, and if they do, how are you going to define it?

Indirect ophthalmoscopy is the gold standard for ROP diagnosis, but it comes with multiple challenges: logistical difficulties, legal liability, reproducibility problems, and a skills gap. Is telemedicine the answer?

How to get the most out of mentorship

A new association is identified between sleep apnea and AMD, which could put the OSA and POAG theory to bed

Sitting Down With... George L. Spaeth, Louis J. Esposito Research Professor, and Director Emeritus, Glaucoma Service, Wills Eye Hospital, Philadelphia, Pennsylvania, USA.